Innovative implantable bio-artificial pancreas for the treatment of diabetes patients No More Frequent Glucose Monitoring & Insulin Injections Beta-O2  is Proposing a Life-Changing Benefit to Diabetes Patients  
 
 

Beta-O2 is Proposing a Life-Changing Benefit to Diabetes Patients

Beta-O2 Technologies Ltd. is a biomedical company developing a proprietary implantable bio-artificial pancreas, the ßO2. This implantable device is designed as a treatment for insulin dependent patients.

The ßO2 is a small device that is implanted subcutaneously in a quick minimally invasive procedure. The device contains islets of Langerhans (containing insulin-producing cells), which are continuously oxygenated and nourished through Beta-O2's proprietary technology.

The islets of Langerhans in the ßO2 sense glucose levels in the body and secrete the corresponding levels of insulin necessary to maintaining normal glucose levels.

This novel technology enables diabetic insulin dependent patients to live with balanced glucose levels and without frequent glucose monitoring and insulin injections.

No more frequent glucose monitoring and insulin injections.

 
© Beta-O2 - Implantable bio-artificial pancreas for the treatment of diabetes     Back to Top  |  Created by Volle'